Compare Cronos Group Inc (CRON) vs iShares Russell 2000 ETF (IWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs iShares Russell 2000 ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while iShares Russell 2000 ETF trades at $278.83 (market cap $78.56B). The key difference: iShares Russell 2000 ETF is far larger — about 65.5× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (450,387 versus 24,585,463). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and iShares Russell 2000 ETF for 83 Days on average.
| CRON | IWM | |
|---|---|---|
Market Cap | $1.20B | $78.56B |
Volume | 450,387 | 24,585,463 |
Sector | Health | — |
52-Week High | $3.55 | $305.06 |
52-Week Low | $2.30 | $229.13 |
Typical Hold Time | 22 Days | 83 Days |
Enterprise Value | $401.73M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
IWM trades at $277.72, down 1.27% with bearish technical signals from moving averages and key indicators. The ETF faces headwinds from Federal Reserve rate hikes and underperformance relative to large-cap indices. Recent news highlights IWM's decade-long trailing of the S&P 500 while carrying higher risk, with institutional selling pressure emerging.
The outlook remains challenging as small-caps face tightening financial conditions and energy price pressures. Investment opportunity exists for long-term value investors seeking diversification from tech-heavy large-caps, though near-term risks include continued Fed hawkishness and weak small-cap breadth in the current market environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →
